Usa Financial Portformulas Corp Ani Pharmaceuticals Inc Transaction History

Usa Financial Portformulas Corp

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 27, 2023	SELL	$50.28 - $64.61 $251 - $323	-5 Reduced 9.26%	49 $2,000
Q2 2023 Nov 27, 2023	BUY	$37.29 - $53.83 $2,013 - $2,906	54 New	54 $2,000
Q4 2019 Feb 07, 2020	SELL	$55.65 - $79.83 $389 - $558	-7 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$64.7 - $85.39 $452 - $597	7 New	7 $1,000

210

18.2M

11.7K

10.5K

Ticker ANIP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 17,426,000
Market Cap $1.01B
Description
ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States and Canada. It focuses on producing controlled substances, oncology products, hormones and steroids, injectables, and other formulations. The company manufactures oral solid dose produc...

Get notified when there are updates to the investment portfolio of Usa Financial Portformulas Corp, based on Form 13F filings with the SEC.

Stay updated on Usa Financial Portformulas Corp with notifications on news.